Accumulating evidence demonstrated that glial cells, especially the astrocytes participated in neuronal communication and regulation of synaptic plasticity (Panatier et al., [@B11]; Henneberger et al., [@B5]). In contrast to the presynaptic inhibitory roles, the type-1 cannabinoid receptors (CB~1~) expressed on astrocytes play a crucial role in glial-neuronal interactions and potentiate synaptic transmission (Navarrete and Araque, [@B8]). In addition, CB~1~ receptors activation on astrocytes leads to release of D-serine, which modulates synaptic NMDARs and regulates LTP in hippocampus (Papouin et al., [@B12]). On the other hand, another study showed that activation of astroglial CB~1~ receptors resulted in LTD induction at CA3-CA1 synapses and impaired spatial working memory (Han et al., [@B4]). However, it remains unknown whether astroglial CB~1~ receptors regulate D-serine/NMDA receptor signaling during long-term memory processes.

In the recent study, Robin et al. found that CB~1~ receptors in hippocampal astrocytes facilitated long-term novel object recognition (NOR) memory consolidation, by D-serine/NMDA receptor signaling (Robin et al., [@B15]). The authors firstly found that GFAP-CB~1~-KO mice displayed LTP induction and long-term NOR memory deficits as compared to their counterparts, similar to animals treated with NMDARs antagonist. WIN55, 212-2(CB~1~ receptor agonist) induced-increase of Ca^2+^ levels in hippocampal astrocyte was lost in GFAP-CB~1~-KO mice. In preparations of brain slice filed recording with D-serine perfusion, GFAP-CB~1~-KO mice had twice more increased synaptic response than GFAP-CB~1~-WT mice, suggesting for tonic suppression of synaptic functions due to D-serine deficiency; in addition, the reduced LTP in hippocampal slice from GFAP-CB~1~-KO mice could be rescued by exogenous application of D-serine.

The researchers then employed multiple approaches to increase D-serine levels *in vivo* and found that the memory deficits of GFAP-CB~1~-KO mice could be rescued by increase of endogenous or exogenous D-serine levels. Moreover, mice lacking CB~1~ gene specifically in hippocampal astrocytes demonstrated similar memory deficits that could be reversed by systemic injection of D-serine as the GFAP-CB~1~-KO mice. This excluded the possibility that alterations of D-serine levels in the hippocampus were resulted from deletion of CB~1~ receptors in other brain regions.

Previous study blocked hippocampal LTP induction by clamping internal Ca^2+^ in individual CA1 astrocytes, which could be reversed by exogenous D-serine, whereas disruption of D-serine exocytosis and depletion of the stored D-serine in an individual astrocyte blocked local LTP (Henneberger et al., [@B5]). Robin et al. further explored the mechanism of recognition memory involving the astroglial CB~1~ receptors. Notably, the poor performance of GFAP-CB~1~-KO mice in recognition memory could be rescued via the increase of the D-serine levels. In addition, GFAP-CB~1~-KO mice had twice more increased synaptic response to application of the D-serine than GFAP-CB~1~-WT mice; these data suggested that astroglial CB~1~ receptors play a crucial role in maintaining appropriate concentrations of extracellular D-serine to keep NMDAR co-agonist sites unsaturated in baseline conditions (Henneberger et al., [@B5]; Robin et al., [@B15]).

The present study demonstrated the role of CB~1~ receptors in astrocytes and one of gliotransmitters D-serine in recognition memory. In fact, the acquisition and consolidation of memory also recruit other neuron--glia signaling pathways. For instance, Vignoli et al. found that astrocytes were engaged in BDNF recycling; mice deficient in BDNF recycling displayed NOR memory deficits (Vignoli et al., [@B17]). Moreover, in addition to D-serine, astrocytes in hippocampus can release glutamate and ATP, which might modulate LTP or LTD via different mechanisms (Navarrete et al., [@B9]; Schmitt et al., [@B16]).

There were still some limitations for the present study. For instance, the effects of D-serine on presynaptic NMDARs and postsynaptic NMDARs remain unknown. Presynaptic NMDARs are also required for LTP at cortical projections to striatum (Humeau et al., [@B6]; Park et al., [@B13]), and may contribute to the enhancement of glutamate release at CA3 to CA1 synapses after LTP induction (Mcguinness et al., [@B7]). Astrocytes exchange information with both presynaptic terminals and post-synaptic receptors, and this existence of bidirectional communication established the concept of "tripartite synapse" (Figure [1](#F1){ref-type="fig"}) (Araque et al., [@B3]; Perea et al., [@B14]; Oliveira da Cruz et al., [@B10]). In tripartite synapse, astrocytes can release multiple gliotransmitters and even a single gliotransmitter can activate different target (Araque et al., [@B2]). For instance, astrocytes can release D-serine acted as a co-agonist of the postsynaptic NMDARs necessary for the induction of hippocampal LTP (Henneberger et al., [@B5]), and D-serine can also act as a co-agonist of the presynaptic NMDARs, which is necessary for the induction of hippocampal t-LTD (Andrade-Talavera et al., [@B1]). Last but not least, there is no direct evidence showing how the increases of calcium level in astrocytes control the release of D-serine.

![Bidirectional Communication in Tripartite Synapse. Astrocytes exchange information with the pre-and postsynaptic neurons. Endocannabinoids (eCBs) can bind to astrocytic CB1 receptors (CB~1~Rs) and presynaptic CB~1~Rs. Activation of astrocytic CB~1~Rs results in increase of Ca^2+^ levels in astrocytes; astrocytic release of glutamate or D-serine can bind to postsynaptic and presynaptic NMDARs to modulate LTP and LTD.](fphar-09-00988-g0001){#F1}

To sum, neuron-glia interaction are important regulators in memory network, especially through astrocytic CB~1~R-mediated D-serine release and the modulation on synaptic functions.
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